SCHEMBL6498723

SCHEMBL6498723

CC(C)Oc1ccccc1Oc1cccc(C=O)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 1/20 0.50
ALDH1A1 P00352 3/20 0.46
LMNA P02545 2/20 0.46
MAPT P10636 2/20 0.46
KMT2A Q03164 2/20 0.46
MEN1 O00255 1/20 0.46
ALDH1A3 P47895 1/20 0.45
MAOA P21397 5/20 0.44
MAOB P27338 5/20 0.44
NPSR1 Q6W5P4 2/20 0.43
SRC P12931 1/20 0.43
POLB P06746 1/20 0.43
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2075852 0.83 TTR (0.67) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL599867 0.82 ALDH1A3 (0.60) ALDH1A1MAPTKMT2AMEN1ALDH1A3
SCHEMBL29951428 0.82 ALDH1A3 (0.60) ALDH1A1MAPTKMT2AMEN1ALDH1A3
SCHEMBL6498828 0.82 TTR (0.47) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL4233381 0.80 TTR (0.50) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL30644948 0.80 TTR (0.50) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL10516870 0.77 TTR (0.46) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL6503830 0.77 NPC1 (0.50) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL4294454 0.76 ALDH1A1 (0.49) TTRALDH1A1LMNAMAPTKMT2A
SCHEMBL5896124 0.76 MAPT (0.49) TTRALDH1A1LMNAMAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor MILLENNIUM PHARMACEUTICALS, INC. 2005-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050143372-A1 Compounds, pharmaceutical compositions and methods of use therefor CCR8, CCL11, CCR5 TTR 4487/4885ALDH1A1 1071/4885LMNA 4603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.